Pfizer
Tanya Alcorn has extensive work experience in the healthcare industry. Tanya currently serves as a Member of the Board of Directors at the Healthcare Businesswomen's Association. Previously, they held various leadership positions at Pfizer, including Senior Vice President Operations, Vice President of BioPharma Global Supply Chain, and Vice President of Global Supply Chain for Pfizer Essential Health Business. Tanya has also served as a Senior Director in the Rare Disease Supply Chain and the Biotech Network Strategy Implementation Leader at Pfizer. Their expertise lies in demand, supply, and inventory management, global supply chain planning, and quality assurance.
Tanya Alcorn earned a Masters in Engineering in Systems Engineering from Stevens Institute of Technology in 2005. Tanya also received a Bachelor's degree in Biological Science from Rutgers University, but the specific start and end years are not provided. Moreover, they studied Biology, General at Rutgers University, but the degree name is not mentioned.
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.